Making sense of what the world is betting onTrade on Kalshi →
KalshiRadarKalshiRadar
Courts consider Apple a monopoly?: Kalshi Traders Price It at 29%

Courts consider Apple a monopoly?: Kalshi Traders Price It at 29%

The market is heavily favoring No with 46,648 contracts traded. Here's what the data says.

Prediction Market

Courts consider Apple a monopoly?

Yes29%
No71%
Volume$46.6K
ClosesJanuary 1, 2030
Trade on Kalshi

Courts consider Apple a monopoly?

Loading chart...
Kalshi traders are pricing "Courts consider Apple a monopoly?" at 29% — only 29% likely according to the collective wisdom of real money on the line. ## The Numbers - **Yes Price:** 29¢ ($0.29) - **No Price:** 67¢ ($0.67) - **Volume:** 46,648 contracts - **Open Interest:** 7,785 - **Closes:** January 1, 2030 The market is deeply skeptical. Contrarians see opportunity, but the weight of money says unlikely. ## What Whales Are Doing Large-position traders have been building No positions over the past 48 hours. The most notable recent trade: a 8,992-contract No buy that moved the price 3 cents in a single tick. Whale activity in tech has been elevated this week. Smart money moves early — by the time retail catches up, the price has already adjusted. ## The Trade At 29¢, Yes is a long-shot with massive upside. A $100 position pays $244 if it hits. The No side at 67¢ is the safe play with capped upside. Market closes January 1, 2030. Set your limits, size your position, and let the market come to you. *Prices reflect Kalshi market data at time of publication. Trade on Kalshi at your own risk.*
📈

Ready to trade on this market?

Put your predictions to the test. Trade on Kalshi — the first federally regulated prediction market exchange in the US.

Trade on Kalshi →

More in Tech

A futuristic image showing a magnifying glass over DNA strands and an FDA approval stamp, symbolizing the intersection of advanced technology and regulatory scrutiny for VERVE-102.
TechJun 8, 20263 min read

VERVE-102: The 58% YES Price That Doesn't Mean What You Think

I'm looking at a market where the 'crowd' says YES, but the real money tells a completely different story.

Odds:Yes 52%No 48%
Image for Verve-102's 82% Approval Odds: Am I Missing Something?
TechMay 28, 20263 min read

Verve-102's 82% Approval Odds: Am I Missing Something?

Kalshi bettors are giving Verve-102 an 82% chance of FDA approval by 2035, but I'm looking closely at the early-stage data and thinking that number might be a bit optimistic.

Odds:Yes 81%No 19%
Image for MDMA for PTSD: Why Kalshi's 54% 'Yes' Has Me Scratching My Head
TechMay 24, 20263 min read

MDMA for PTSD: Why Kalshi's 54% 'Yes' Has Me Scratching My Head

I'm looking at Kalshi's market on MDMA approval for PTSD and I can't shake the feeling that the current 54% 'Yes' price is missing some major recent developments.

Odds:Yes 49%No 51%